Mr. Berger joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of peri- and post-marketing product development programs and Real-World Evidence generation. Mr. Berger supports the development of RWD / RWE architectures and solutions to drive greater insight into the safety profile and value proposition of treatments.